Conmed (CNMD) Misses Q4 EPS by 1c; Guidance Misses

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Conmed (CNMD) Misses Q4 EPS by 1c; Guidance Misses

CONMED (CNMD) PT Raised to $56 at Summer Street Post Q4

January 28, 2015 8:18 AM EST

Summer Street analyst Mark Landy reiterated a Buy rating and boosted his price target on CONMED (NASDAQ: CNMD) to $56.00 (from $46.00)

Landy commented, "Yesterday CNMD reported 4Q14 revenues in line with the January 14 preannouncement. Revenues and EPS were $195MM and $0.53, respectively. As CNMD carries meaningful FX hedges, given its outsized exposure to international markets (~50%... More